Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractInvestigation of carbonyl compound sources at a rural site in the Yangtze River Delta region of China    Next AbstractCarbon quantum dots embedded mesoporous silica for rapid fluorescent detection of acidic gas »

J Breath Res


Title:Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer
Author(s):Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P;
Address:"Biosensor National Special Laboratory, Key Laboratory for Biomedical Engineering of Ministry of Education, Department of Biomedical Engineering, Zhejiang University, Hangzhou, People's Republic of China. State Key Laboratory of Transducer Technology, Chinese Academy of Sciences, Shanghai 200050, People's Republic of China"
Journal Title:J Breath Res
Year:2018
Volume:20180914
Issue:4
Page Number:46013 -
DOI: 10.1088/1752-7163/aad9cc
ISSN/ISBN:1752-7163 (Electronic) 1752-7155 (Linking)
Abstract:"Lung cancer (LC) is a leading cause of cancer-related morbidity and mortality globally, and exhaled breath testing has been considered as a fast, convenient and non-invasive way to diagnose LC in its early stages. Volatile organic compounds (VOCs), as markers of LC in exhaled breath, have been widely investigated for cancer diagnosis. However, few studies have reported on the interference of benign pulmonary diseases (BPD) in the selection of VOC markers for LC. During this study, 207 samples were analyzed using thermal desorption instrumentation/gas chromatography/mass spectrometry (TD-GCMS) to detect C(6)-C(30) VOCs, and all samples were divided into four groups: LC group, BPD group, lung disease (LD) group (including LC group and BPD group) and healthy group. To make up for the deficiency of detecting low carbon hydrocarbons (
Keywords:"Biomarkers, Tumor/*analysis Body Fluids/chemistry Breath Tests Case-Control Studies Confounding Factors, Epidemiologic Exhalation Female Gas Chromatography-Mass Spectrometry Humans Lung Diseases/*diagnosis Lung Neoplasms/*diagnosis/*epidemiology Male Midd;"
Notes:"MedlineWang, Min Sheng, Jiajing Wu, Qian Zou, Yingchang Hu, Yanjie Ying, Kejing Wan, Hao Wang, Ping eng Research Support, Non-U.S. Gov't England 2018/08/14 J Breath Res. 2018 Sep 14; 12(4):046013. doi: 10.1088/1752-7163/aad9cc"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 27-12-2024